PMC Group N.A., Inc. (Mount Laurel, N.J.; www.pmc-group.com) and the Organometallics business of Lanxess AG (Cologne, Germany; www.lanxess.com) announced that the parties have reached an agreement whereby PMC’s European subsidiary will acquire the organotin specialties product line (the Business) from Lanxess. The transaction is scheduled to close by year end, subject to customary closing conditions.
The Business includes Lanxess’ global organotin catalyst, organotin specialties and intermediates product lines. The transaction includes a toll manufacturing agreement under which Lanxess will continue to manufacture certain products post-closing for PMC at its Bergkamen, Germany organometallics manufacturing facility.
Mr. Debtosh Chakrabarti, President of PMC said, “This acquisition represents PMC’s continuing commitment to the organotin industry and is synergistic to our existing organometallics and catalyst businesses. We believe that the customer base of the Business as well as all of PMC’s customers will benefit significantly from combining the technology base and experience of the organometallics business with PMC’s global supply chain, technology and manufacturing capabilities and focus on innovative solutions and technical service in this industry.”